caretrace.iopowered by▸healthparse
SearchCohort Builder
Tools▾
KOL FinderTerritoriesDrug Compare
AI Query
Browse▾
By stateBy specialty
Pricing
SearchCohort BuilderToolsKOL FinderTerritoriesDrug CompareAI QueryBrowseBy stateBy specialtyPricing
PROVIDER PROFILE · NPI 1003045410

Patsy HollowayFNP BC

PRACTICERUSH MEDICAL FOUNDATIONSee all providers at this practice →
Nurse PractitionerQuitman, MSI
CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore
OIG/SAM exclusion screening, sanctions history
© 2026 CareTrace
PricingContactPrivacyTerms
FACILITY AFFILIATIONS

Hospital & Facility Affiliations (2)

CCN 251316
Hospital
CCN 251335
Hospital
MEDICARE UTILIZATION · PART B · 2024
Total beneficiaries
165
Unique beneficiaries
—
Total services
368
Distinct HCPCS
6
Medicare payment
$17K
Peer benchmark
Q1
Q2
Q3
Q4
Q5
Total Medicare services vs. 3,111 Nurse Practitioner providers in MS — below median (cohort median 434).
REFERRAL NETWORK

Where Patsy Holloway's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 3 inbound referrers · 4 outbound destinations.

Receives referrals from
Inbound — who sends patients here
PhysicianPatientsVisits
ALLEN, SAMUEL22143
RUSH MEDICAL FOUNDATION1683
RUSH MEDICAL FOUNDATION1622
Refers patients to
Outbound — where patients go next
PhysicianPatientsVisits
ALLEN, SAMUEL2198
RUSH MEDICAL FOUNDATION1443
RUSH MEDICAL FOUNDATION1350
RUSH MEDICAL FOUNDATION1226
Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.
PRESCRIBING · PART D · 2024
Total Rx claims
103
Beneficiaries
—
Total drug cost
$6K
Distinct drugs
7
Brand share
26.2%
Top prescribed drugs
Furosemide23 claims
Hydrocodone/Acetaminophen15 claims
Prednisone15 claims
Pantoprazole Sodium14 claims
Levothyroxine Sodium13 claims
QUALITY · MIPS · 2024
Final MIPS score
85.2
Quality
78.4
Cost
0.0
Improvement activities
40.0
Promoting interop.
0.0
Payment adjustment
0.43%
Group
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024
No data available for this provider in 2024.